首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

2008089

外用皮質類固醇市場：按劑型、應用、通路和地區分類

Topical Corticosteroids Market, By Formulation, By Application, By Distribution Channel, By Geography

出版日期: 2026年03月18日 | 出版商:

Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，外用皮質類固醇市值將達到46.3億美元，到2033年將達到61.5億美元。預計從2026年到2033年，其複合年成長率將達到4.1%。

分析範圍		分析詳情
基準年	2025	市場規模（2026 年）	46.3億美元
效能數據	2020-2024	預測期	2026-2033
預測期（2026-2033 年）複合年成長率	4.10%	預計金額（2033 年）	61.5億美元

外用類固醇有多種濃度，依其效力分為七類。 I類類固醇效力最強，而VII類類固醇效力最弱。

I類局部固醇的效力是VII類類固醇的600到1000倍。合適的類固醇強度或效力取決於多種因素。

例如，嬰兒和幼兒吸收外用類固醇的速度比成人快得多，因此他們可能需要效力較低的類固醇。

外用類固醇在皮膚與肌肉緊密接觸的部位（如腋窩或乳房下方）或敏感皮膚區域（如眼瞼）很容易被吸收，因此低效配方可能就足夠了。

市場動態

市場參與者正致力於推出學名藥，預計這將有助於預測期內全球外用皮質類固醇（類固醇）市場的成長。例如，2019年3月，印度製藥公司Lupin Limited宣布推出0.05%氟輕鬆軟膏（Fluocinonide Ointment USP 0.05%），該產品於2018年7月獲得美國食品藥物管理局（FDA）的核准。 Lupin的0.05%氟輕鬆軟膏是County Line Pharmaceuticals LLC的0.05%利德士軟膏（Lidex Ointment 0.05%）的學名藥藥。它用於治療與皮質類固醇反應性皮膚病相關的發炎和瘙癢症狀。

市場參與企業正採取收購等策略，預計這將有助於全球外用皮質類固醇（類固醇）市場的成長。例如，2018年10月，專業製藥公司Meine Pharma宣布以3,200萬美元收購了0.05%鹵倍他索泡棉劑在美國和澳洲的銷售權。鹵倍他索泡沫劑是一種強效皮質類固醇，用於治療斑塊型乾癬。

非營利組織為改善濕疹治療所做的努力日益增加，預計將推動全球外用皮質類固醇（類固醇）市場在預測期內成長。例如，2021年9月，在世界濕疹日（9月14日），來自八個國家的11個患者組織聯合推出了「全球改善濕疹護理患者舉措」（GPIIEC）。該計劃旨在製定統一標準，用於評估醫療保健系統滿足患者和看護者需求的程度。這項開創性的合作揭示了醫療保健服務中對患者和看護者至關重要的方面，並確定了八個已開發國家（澳洲、加拿大、丹麥、法國、義大利、德國、英國）的評估指標。

本報告的主要特點

本報告指出了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
本文根據以下參數，介紹了全球局部皮質類固醇（類固醇）市場主要企業的概況：公司概況、產品系列、主要亮點、財務績效和策略。
本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、產品線更新、市場擴張和行銷策略做出明智的決策。
《全球外用皮質類固醇（類固醇）市場》報告面向該行業的各種相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過分析全球外用皮質類固醇（類固醇）市場中使用的各種策略矩陣來促進決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太地區
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 南非
- 中非
- 北非

第8章競爭情勢

公司簡介
- GlaxoSmithKline plc
- Merck &Co., Inc.
- Sandoz International GmbH
- AstraZeneca
- LEO Pharma
- Cipla Inc.
- Bristol-Myers Squibb Company
- Almirall, SA
- Bausch Health
- Sanofi SA

第9章

參考
分析方法

簡介目錄

Product Code: CMI5035

Topical Corticosteroids Market is estimated to be valued at USD 4.63 Bn in 2026 and is expected to reach USD 6.15 Bn by 2033, growing at a compound annual growth rate (CAGR) of 4.1% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 4.63 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	4.10%	2033 Value Projection:	USD 6.15 Bn

Topical steroids are available in a variety of strengths and are classified into seven classes based on their potency. Class I (class one) contains the strongest steroids, while Class VII contains the weakest (class seven).

Topical steroids in Class I are 600 to 1,000 times more powerful than those in Class VII. The right steroid strength, or potency, is determined by a number of factors.

Babies, for example, absorb topical steroids much faster than adults, so a low-potency steroid may be required.

Topical steroids are absorbed quickly in parts of the body where skin touches flesh, such as the armpits or beneath the breasts, or in sensitive areas of skin, such as the eyelids, and may only require a low-potency formulation.

Market Dynamics

Market players are focused on launching generic products, this is expected to contribute to growth of the global topical corticosteroids (steroids) market over the forecast period. For instance, in March 2019, Lupin Limited, an Indian pharmaceutical company announced the launch of Fluocinonide Ointment USP, 0.05 %, which was approved by the US Food and Drug Administration (FDA) in July 2018. Lupin's Fluocinonide Ointment USP, 0.05% is the generic equivalent of County Line Pharmaceuticals LLC's Lidex Ointment 0.05%. It is used to treat inflammatory and pruritic symptoms associated with corticosteroid-responsive dermatoses.

Market players are involved in strategies such as acquisitions, which is expected to contribute to growth of global topical corticosteroids (steroids) market. For instance, in October 2018, Mayne Pharma, a specialty pharmaceutical company, announced that it has acquired the US and Australia rights to halobetasol foam 0.05% for US$32.0 million. Halobetasol foam is a highly potent corticosteroid that is used to treat plaque psoriasis.

Increasing initiatives by non-profit organizations for better treatment of eczema is expected to aid growth of the global topical corticosteroids (steroids) market over the forecast period. For instance, in September 2021, on world eczema day (September 14), eleven patient organizations from eight countries came together to launch the Global Patient Initiative to Improve Eczema Care (GPIIEC). The programme is a global effort to develop a uniform yardstick for evaluating how well health systems respond to demands of patients and their caregivers. This groundbreaking collaboration has discovered aspects of health-care delivery that matter most to patients and caregivers, as well as indicators to assess them across eight developed countries (Australia, Canada, Denmark, France, Italy, Germany, United States, and the United Kingdom).

Key features of the study

This report provides an in-depth analysis of global topical corticosteroids (steroids) market , provides market size (US$ Billion), and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global topical corticosteroids (steroids) market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include GlaxoSmithKline plc, Merck & Co., Inc., Sandoz International GmbH, AstraZeneca, LEO Pharma, Cipla Inc., Bristol-Myers Squibb Company, Almirall, S.A., Bausch Health, and Sanofi SA
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global topical corticosteroids (steroids) market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global topical corticosteroids (steroids) market.

Market Segmentation

By Formulation
- Creams
- Ointments
- Gels
- Others (solutions, foams, spray, etc.)
By Application
- Acne
- Dermatitis
- Psoriasis
- Eczema
- Hyperpigmentation
- Others (rash, etc.)
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
Key Players
- GlaxoSmithKline plc
- Merck & Co., Inc.
- Sandoz International GmbH
- AstraZeneca
- LEO Pharma, Cipla Inc.
- Bristol-Myers Squibb Company
- Almirall, S.A.
- Bausch Health
- Sanofi SA

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Formulation
- Market Snippet, By Application
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Drivers
Restraints
Market Opportunities
Regulatory Scenario
Industry Trends
Merges and Acquisitions
New System Launch/Approvals
Value Chain Analysis
Porters Analysis
PEST Analysis

4. Global Topical Corticosteroids (steroids) Market, By Formulation, 2026-2033 (USD Bn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Creams
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
Ointments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
Gels
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)

5. Global Topical Corticosteroids (steroids) Market, By Application, 2026 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Acne
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
Dermatitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
Psoriasis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
Eczema
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
Hyperpigmentation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)

6. Global Topical Corticosteroids (steroids) Market, By Distribution Channel, 2026 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)

7. Global Topical Corticosteroids (steroids) Market, By Region, 2026 - 2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2018-2030
- Regional Trends
North America
- Market Size and Forecast, By Formulation, 2026-2033 (USD Bn)
- Market Size and Forecast, By Application, 2026-2033 (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026-2033 (USD Bn)
- Market Size and Forecast, By Country, 2026-2033 (USD Bn)
  - U.S.
  - Canada
Latin America
- Market Size and Forecast, By Formulation, 2026-2033 (USD Bn)
- Market Size and Forecast, By Application, 2026-2033 (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026-2033 (USD Bn)
- Market Size and Forecast, By Country, 2026-2033 (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Market Size and Forecast, By Formulation, 2026-2033 (USD Bn)
- Market Size and Forecast, By Application, 2026-2033 (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026-2033 (USD Bn)
- Market Size and Forecast, By Country, 2026-2033 (USD Bn)
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Size and Forecast, By Formulation, 2026-2033 (USD Bn)
- Market Size and Forecast, By Application, 2026-2033 (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026-2033 (USD Bn)
- Market Size and Forecast, By Country, 2026-2033 (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Formulation, 2026-2033 (USD Bn)
- Market Size and Forecast, By Application, 2026-2033 (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026-2033 (USD Bn)
- Market Size and Forecast, By Country/Region, 2026-2033 (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Market Size and Forecast, By Formulation, 2026-2033 (USD Bn)
- Market Size and Forecast, By Application, 2026-2033 (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026-2033 (USD Bn)
- Market Size and Forecast, By Country/Region, 2026-2033 (USD Bn)
  - South Africa
  - Central Africa
  - North Africa

8. Competitive Landscape

Company Profiles
- GlaxoSmithKline plc
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Merck & Co., Inc.
- Sandoz International GmbH
- AstraZeneca
- LEO Pharma
- Cipla Inc.
- Bristol-Myers Squibb Company
- Almirall, S.A.
- Bausch Health
- Sanofi SA